Information about Neuraxpharm Belgium
My details
*
*
*

Company information

Status
Active

Enterprise number

BE0793.136.336

VAT liability
Yes
Established
28-10-2022
Last balance sheet year
2023
Company size
Small 0 FTE
Principal activity
Wholesale of pharmaceutical and medical goods
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Neuraxpharm Belgium

2023 2022
Profit/Loss -436,979 -2064 % -20,197
Equity -452,176 -2875 % -15,197
Gross margin -193,684 -859 % -20,197

Publications from Neuraxpharm Belgium

Date Publication
14-05-2025 Resignations, Appointments (FR)
28-01-2025 Registered Office (FR)
31-12-2024 Resignations, Appointments (FR)
26-09-2024 Resignations, Appointments (FR)
03-11-2022 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (FR)

Frequently asked questions

What is the VAT number of Neuraxpharm Belgium?
The VAT number of Neuraxpharm Belgium is BE 0793.136.336.
Wat is the PEPPOL ID of Neuraxpharm Belgium?
The PEPPOL ID of Neuraxpharm Belgium is 0208:0793136336. Log in or start a free trial to see the full overview.
When was Neuraxpharm Belgium founded?
Neuraxpharm Belgium was founded on 28-10-2022.
What is the address of Neuraxpharm Belgium?
The current registered office of Neuraxpharm Belgium is located at Boulevard Saint-Lazare 4/10, 1210 Saint-Josse-ten-Noode.
When was the last time Neuraxpharm Belgium filed their annual financial statements?
The most recent financial statements of Neuraxpharm Belgium were filed on 17-09-2024.
How many employees does Neuraxpharm Belgium have?
There are currently no employees working at Neuraxpharm Belgium or no workforce information is available.
What is the annual turnover of Neuraxpharm Belgium?
At the time of its most recent financial statements, Neuraxpharm Belgium did not publish any turnover figures. Neuraxpharm Belgium reported a gross margin of -€193,684.03.